Drawing on the wealth of available data about human biology and genomics, as well as the in-house expertise of a global network of researchers, NIBR has developed new and important therapies.
To raise awareness of the sudden and profound impact of meningococcal disease on families across the globe, world-renowned photographer Anne Geddes has joined forces with the Confederation of Meningitis Organizations (CoMO) and Novartis Vaccines and Diagnostics for the Protecting Our Tomorrows: Portraits of Meningococcal Disease project.
Today, many companies are trying to solve global health challenges through philanthropy. However, it has become clear that philanthropy alone is no longer enough to make a lasting impact.
Using new technologies, researchers have developed a deeper understanding of how cells function, changing conceptions of disease.
University students majoring in the life sciences or business often have trouble imagining the direction of their careers.
Do answers to the mysteries of cancer lie hidden within the DNA of tumor cells? Researchers think so.
Most people have never heard of spinal muscular atrophy (SMA), a rare genetic disease that affects approximately 1 in 6,000 babies born worldwide each year. Innovative research may produce treatments for patients suffering from SMA and other rare diseases.
Novartis is one of this year’s top 20 employers in an annual survey from Science.
Emerging markets in Africa are gearing up for clinical research. Learn how Novartis is working with Ghana and Kenya to build research capacity.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society ESG report.
This site is intended for a global audience.